Jane Gitschier, PhD

Professor Emeritus of Medicine and of Pediatrics


Jane Gitscher, PhD
Dr. Gitschier is interested in discovering the genetic basis for absolute pitch, the uncanny ability to identify the pitch of a tone without a reference tone. This study has generated new insights into pitch perception. A second research area involves genetic genealogy and privacy. With a passion for genetics history, she is also the interviews editor for the open access journal PLoS Genetics and is currently working on a book project on the dawn of human molecular biology in the 1970s.

Barbara Koenig, PhD

Professor, Institute for Health and Aging, and Department of Anthropology, History, and Social Medicine

Director, UCSF Bioethics

UCSF Faculty Profile

Barbara Koenig, PhD
Dr. Koenig is an anthropologist working in the inter-disciplinary field of bioethics. She founded and led Biomedical Ethics Research Programs at Stanford and Mayo Clinic. Dr. Koenig pioneered the use of empirical methods in the study of ethical questions in science, medicine, and health. Her current interests include characterizations of race in a genomics age, emerging genomic technologies, including biobanking, return of research results to participants, and using deliberative democracy to engage communities about research governance. She has been an active participant in policy development both at a federal level and through her role as fellow of the Hastings Center.

Miriam Kuppermann, PhD

Professor of Obstetrics, Gynecology & Reproductive Sciences

Website | UCSF Faculty Profile

Miriam Kuppermann, PhD
Dr. Kuppermann has an active research program focusing on informed decision making in the context of prenatal and adult genetic testing. Dr. Kuppermann has led numerous NIH, AHRQ, foundation and industry-funded studies of these issues in socio-demographically diverse populations, which have included conducting extensive formative research on patient preferences and experiences, developing decision tools with values clarification components, and conducting randomized controlled trials of the effectiveness of these tools among patients facing genetic testing decisions.